TD Cowen raised the firm’s price target on Humana (HUM) to $268 from $261 and keeps a Hold rating on the shares. The firm said the company updated guidance as management contemplates targeted investments for future growth and Stars recoupment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana price target lowered to $290 from $387 at Wells Fargo
- Humana price target lowered to $290 from $395 at Cantor Fitzgerald
- Humana price target raised to $253 from $250 at Barclays
- Humana’s Medicare Advantage Star Ratings Drop: Legal Battle Looms Over 2025 Projections and Potential Revenue Impact
- Humana Inc. Reports Mixed Q3 2024 Results